Showing results (501-510 of 734) with videos related to

Sort By:
Pageof 74
Blood|May 3, 2002
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasiaAyalew Tefferi, Ruben A Mesa, Leigh A Gray, et al.
Mayo Clinic Proceedings|February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
Transplantation and Cellular Therapy|May 13, 2022
Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell TransplantSurbhi Sidana, Amylou C Dueck, Gita Thanarajasingam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2018
Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2018
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US CohortsClémentine Sarkozy, Matthew J Maurer, Brian K Link, et al.
British Journal of Haematology|November 19, 2013
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemiaAneel Paulus, Kasyapa Chitta, Sharoon Akhtar, et al.
Transplantation and Cellular Therapy|June 25, 2022
Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell LymphomaAung M Tun, Seth Maliske, Yucai Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2019
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysisAngelo Fama, Melissa C Larson, Brian K Link, et al.
Blood Cancer Journal|October 11, 2018
Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphomaKerstin Wenzl, Michelle K Manske, Vivekananda Sarangi, et al.
British Journal of Haematology|May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphomaRobert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Pageof 74